1st consortium about microbiome & cancer, led by Gustave Roussy
Gustave Roussy, leading European Cancer Centre, is collaborating with 16 international partners in the Oncobiome consortium. The objective of the programme is to determine the relationship between intestinal microbial signatures (GOMS) and the incidence, prognosis and resistance to treatment (and toxicity of this) in cancers of breast, colon, lung and melanoma.
Created in the context of the 2020-2025 institutional strategic plan, the Interdisciplinary Department for the Organization of Patient Pathways (DIOPP) has one objective: to streamline care circuits while personalizing the overall support for Gustave Roussy patients from before to after cancer.
The activities and services grouped together in this department deal with many aspects of care circuits:
Grâce aux progrès thérapeutiques de ces dernières décennies, 80 % des enfants et adolescents guérissent de leur cancer. Mais souvent au prix de lourdes séquelles.